rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Burke W. Whitman

Director

Company insider

Files Form 4 as: Director, Omega Healthcare Investors; Director, Amicus Therapeutics; President and CEO, Health Management Associates.

Every Form 4 they filed

In numbers

Trades disclosed
116
Buys
38
Sells
0
Bought
$3.2M
Sold
$0
Companies
3
Companies where not an officer
2
First trade
30 Jan 2006
Last trade
5 Jun 2026
Last filed
9 Jun 2026

Companies traded

Where they are an officer
Health Management AssociatesDirector, Officer · last 7 Aug 20082 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
OHI Omega Healthcare InvestorsDirector · REITs · last 5 Jun 202617 buys · 0 sells
Amicus TherapeuticsDirector · Biotechnology · last 27 Apr 202619 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jun 2026filed 9 Jun 2026OHI Omega Healthcare InvestorsREITsSEC FORM 4 Code A$165K3,778 at $43.67filing
5 Jun 2026filed 9 Jun 2026OHI Omega Healthcare InvestorsREITsSEC FORM 4 Code A$165K3,778 at $43.67filing
27 Apr 2026filed 27 Apr 2026Amicus TherapeuticsBiotechnologySEC FORM 4 Code D$1.7M118,598 at $14.50filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—25,964filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—18,574filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—25,964filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—18,574filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—36,111filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—45,423filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—30,474filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—42,467filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivativeSEC FORM 4 Code D—74,872filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—36,111filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—45,423filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—30,474filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—42,467filing
27 Apr 2026filed 27 Apr 2026Amicus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code D—74,872filing
27 Apr 2026filed 27 Apr 2026Amicus TherapeuticsSEC FORM 4 Code D$1.7M118,598 at $14.50filing
6 Jun 2025filed 10 Jun 2025OHI Omega Healthcare InvestorsREITsSEC FORM 4 Code A$165K4,388 at $37.60filing
5 Jun 2025filed 6 Jun 2025Amicus Therapeuticsoption or derivativeSEC FORM 4 Code A—74,872 at $0.00filing

News

Omega Healthcare Investors (NYSE:OHI) Given New $52.00 Price Target at UBS GroupOHI · dailypolitical.com · 13 Oct 2026Omega Healthcare Investors, Inc. (NYSE:OHI) Stock Has Consensus Target Price of $49.71OHI · dailypolitical.com · 13 Oct 2026

0 headlines in the last 90 days name Burke W. Whitman; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Real Estate17
Not placed21

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.